The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study

NCT02200172 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

OTHER: Melatonin
OTHER: Placebo

Sponsor

Bruyère Health Research Institute.